Investing in the biotech industry is an art, not a science. While the potential for gains from groundbreaking therapies exists, the majority fail. By utilizing statistics, careful selection, and net ...
ACS Fall 2026 is underway in Chicago, where MIT Prof. Connor Coley delivered the Kavli Foundation Lecture on Monday with an ...
Rochester Institute of Technology's lecture series, Biotechnology: Our Future as Human Beings and Citizens, will continue to explore the challenge and promises of the biotechnological revolution by ...